Durable partial response to carboplatin, paclitaxel, and pembrolizumab in squamous cell carcinoma of unknown primary: A case report. // Medical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2949918626000860?dgcid=rss_sd_all
Durable partial response to carboplatin, paclitaxel, and pembrolizumab in squamous cell carcinoma of unknown primary: A case report. Medical Reports. https://www.sciencedirect.com/science/article/pii/S2949918626000860?dgcid=rss_sd_all
“Durable partial response to carboplatin, paclitaxel, and pembrolizumab in squamous cell carcinoma of unknown primary: A case report.” Medical Reports.
@article{article104522,
title = {Durable partial response to carboplatin, paclitaxel, and pembrolizumab in squamous cell carcinoma of unknown primary: A case report},
journal = {Medical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2949918626000860?dgcid=rss_sd_all}
}